GLP-1 analog liraglutide repairs structural damage in obesity-associated glomerulopathy and prevents sciatic nerve dysfunction [34] as it inhibits NF-κB and MAPK pathways. The gene discussed is NFKB1; the disease is lipoprotein glomerulopathy.